Biotechnology Stocks I Performance Guide: Keros Therapeutics, Inc. (KROS)
KROS has no dividends.
Table and Chart of KROS Performance
See what a $1,000 investment in KROS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| KROS Returns | |
|---|---|
| Start Date | May-29-2020 |
| Start Price | $28.74 |
| End Date | May-10-2024 |
| End Price | $54.27 |
| # Prices | 49 |
| Min Date | Jun-30-2022 |
| Min Price | $27.63 |
| Max Date | Nov-30-2020 |
| Max Price | $75.61 |
| Total Return | 88.83% |
| Annualized Return | 16.84% |
| Current Value of $1,000 Purchase | $1,888 |
| Number Returns | 1,176 |
| Average Return | 5.19% |
| Number Profitable Returns | 546 |
| Percent Profitable Returns | 46.43% |
| Number Unprofitable Returns | 630 |
| Percent Unprofitable Returns | 53.57% |
| Profitable to Unprofitable Returns Ratio | 0.87 |
| KROS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,958,273,000 |
| Beta | 1.323 | Price to Sales | 13,966.49 |
| Earnings per Share | $-5.1500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 6.36 |
| PRICE DATA | |
| 52 Week High | $73 |
| 52 Week Low | $27.02 |
| Analyst Target Price | $90.25 |
| 50-Day Moving Average | $62.32 |
| 200-Day Moving Average | $45.13 |
| FINANCIAL DATA | |
| Revenue per Share | $0.007 |
| Revenue | $234,000 |
| Profit Margin | 0% |
| Return on Equity | -39.6% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
KROS Compare Returns with S&P 500
KROS Trendline Chart
KROS Moving Average Chart
KROS Stock Return Map - See Patterns of Gains and Losses
KROS Stock Returns/Purchase Dates